TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07154992: Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in a Healthy Paediatric Popu

Sponsor: Bioithas SL · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 268 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT07154992 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07154992 Rescue Dossier →